Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center

Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center

Objectives: Mutation analysis by massive parallel sequencing (MPS) is routinely performed in the clinical management of lung cancer in Sweden. We describe the clinical and mutational profiles of lung cancer patients subjected to the first 1.5 years of treatment predictive MPS testing in an autonomou...

Full description

Bibliographic Details
Main Authors: Sofi Isaksson, MD, PhD, Bassam Hazem, MD, Mats Jönsson, PhD, Christel Reuterswärd, MSc, Anna Karlsson, PhD, Håkan Griph, MD, Jens Engleson, MD, Gudrun Oskarsdottir, MD, PhD, Ronny Öhman, MD, PhD, Karolina Holm, PhD, Frida Rosengren, MSc, Karin Annersten, BSc, Göran Jönsson, PhD, Åke Borg, PhD, Anders Edsjö, MD, PhD, Per Levéen, PhD, Hans Brunnström, MD, PhD, Kajsa Ericson Lindquist, MD, PhD, Johan Staaf, PhD, Maria Planck, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:JTO Clinical and Research Reports
Subjects:
Lung cancer
Massive parallel sequencing
Driver oncogenes
Chemotherapy
Never smoker
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300138

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320300138

Similar Items